Small Cap Feast

27th February 2024

Dish of the day
No Joiners today
Off the menu
No leavers today

Dish Of The Day:



Whats baking in the oven?

Potential Initial Public Offerings:

Reverse Takeovers:

Change of Market:

Banquet Buffet

Crossword Cybersecurity* 4.25p £4.0m (CCS.L)
The cybersecurity solutions company focused on cyber strategy and risk, announces the launch of Trillion HarVista. Part of the Trillion Threat Intelligence suite of products and services, Trillion HarVista enables security teams, for the first time, to be able to identify threats developing both from hacker discussions and shared compromised credential data all from a single interface, without the risk of searches on hostile websites. HarVista works by quietly making entire offline copies of forums and chats and stores them locally on the Company’s secure servers. The collection process also removes harmful content and attachments ensuring a completely safe browsing experience for organisations wanting to proactively defend against threat actors.

Fusion Antibodies 3.9p £2.4m (FAB.L)
The company focusing on pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces it has received a first purchase order under the master services agreement (MSA) with a diagnostics company (Client). The first purchase order, valued at c. £60k, has been received for an initial project to generate antibodies specifically for the Client's use in diagnostic products. The majority of the revenue under the initial purchase order will be recognised in the next financial year, commencing 1 April 2024.

ITIM Group 37p £11.51m (ITIM.L)
The SaaS based technology company that enables store-based retailers to optimise their businesses announces the contract win of itim's Omni channel retail platform for QUIZ clothing, a fashion retailer specialising in occasion wear and dressy casual wear with 73 stores and 274 concessions in the UK. This is a five year multi-million-pound contract and a significant achievement for itim, as QUIZ is the first fashion retailer in its customer portfolio to implement the end-to-end retail platform as well as its new wholesale module. Itim’s Retail suite product is soon to be rebranded as UNIFY.

Maintel Holdings 235p £33.7m (MAI.L)
The provider of cloud, network and security managed communications services, announces that following the successful completion of the initial phases of the Company turnaround plan, Dan Davies has taken over as Interim CEO, while the Company accelerates its search for a permanent CEO. This allows Carol Thompson to focus on her Executive Chairman role. These changes are effective immediately. Dan has held a number of senior positions at Maintel since 2014, and has been Chief Technology Officer and Executive Director of the Maintel Holdings PLC Board since 2020.

Ocean Harvest Technology 12.5p £15.7m (OHT.L)
The researcher, developer and supplier of proprietary blended seaweed products as functional additives for the global animal feed industry, announces that it has been granted a second patent, covering a wide range of claims about the benefits of using its OceanFeedTM product in the diets of a range of animals. The patent protects the claims: 1) of how OHT's product positively impacts the gut through its proven pre-biotic effect; and, 2) that this results in increased body weight and/or improved feed efficiency in a wide range of animals.

Oracle Power 0.025p £1.2m (ORCP.L)
The international project developer, together with its joint venture company, Oracle Energy Limited (Oracle Energy), announces commencement of the requisite Geotechnical Study and Electrical Resistivity Survey (ERS) in respect of the planned Renewable Power plant on the project site in Jhimpir, in the Sindh Province of Pakistan. The Geotechnical Study will encompass soil investigation and deploy rotary drilling to record rock quality designations and core recovery values. The Electrical Resistivity Survey will determine lithology, porosity and permeability from boreholes drilled.

Proton Motor Power Systems 3p £47.7m (PPS.L)
The designer and producer of hydrogen fuel cells and hydrogen fuel cell electric hybrid systems with a zero-carbon footprint, provides a trading update for the year ended 31 December 2023 (FY 2023). FY 2023 revenue was £2.1m (FY 2022: £2.1m), and a 40% increase in the value of system sales to £2.0m (2022 system sales: £1.4m). Total order intake of £2.5m (2022: £2.7m), of which 37.7% were repeat orders. In total, 42 fuel cell systems were delivered during the period (2022: 23 systems). The Company look forward into 2024.

Silver Bullet Data Services Group 180p £31.4m (SBDS.L)
The provider of digital transformation services and products, announces an extended contract with Mars Petcare US (Mars), which provides pet nutrition, health, and veterinary services as part of Mars, Incorporated. Silverbullet has extended its partnership with Mars for the third consecutive year, for a value of US$2.3m, from January to December 2024. The Company will be broadening its support to Mars across three primary workstreams, specifically dedicated to the implementation of AI driven first party customer data intelligence.

SkinBioTherapeutics 9.75p £18.6m (SBTX.L)
The life science company focused on skin health, announces that interim data from the AxisBiotix Acne food supplement consumer participant study indicates positive results for the lead formulation. The volunteer study, comprising 220 people, followed the same methodology to the AxisBiotix-Ps study, with the supplement containing the lead formulation, being supplied to participants in powder-form. The full study length is 56 days. The Company will continue the study to completion and the analysis and read-out of the final results is anticipated to occur before the end of Q1 2024.

Sondrel Holdings 10.75p £9.4m (SND.L)
A provider of ultra-complex chips for global technology brands, announces that it has won a new design and supply contract for video processing chips with a total estimated value of US$23m. The initial contract value is for over US$9m for the duration of the design and qualification phases and the work will be fully funded by the customer. The contract is expected to generate production revenue of US$14m, over 10 to 15 year production lifetime of the product. The Company also reports that it has received four new orders in 2024 year to date for its design consulting services, engaging with two existing customers and two new customers. These contracts will generate a combined revenue of US$0.9m in the current financial year.


27 February 2024
*A corporate client of Hybridan LLP or retained by Hybridan LLP for certain services
** Arranged by most recent first
*** Alphabetically arranged


Our daily digest of news from UK listed Small and Mid caps straight to your Inbox.


This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.

The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).

Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.

Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.

Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.

MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.

Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.

If you would like to unsubscribe, please email with “unsubscribe me”.

© Copyright 2024 - Hybridan | Website by Boxed Up Media
First Visit
bookcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram